European Union - English - EMA (European Medicines Agency)

merck europe b.v. - avelumab - neuroendocrine tumors - other antineoplastic agents, monoclonal antibodies - bavencio is indicated as monotherapy for the treatment of adult patients with metastatic merkel cell carcinoma (mcc).bavencio in combination with axitinib is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (rcc).bavencio is indicated as monotherapy for the first‑line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc) who are progression-free following platinum‑based chemotherapy.

Canada - English - Health Canada

emd serono, a division of emd inc., canada - avelumab - solution - 20mg - avelumab 20mg - antineoplastic agents

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sdn. bhd. - avelumab -